Vol 89, No 11 (2018)
Guidelines / Expert consensus
Published online: 2018-11-30

open access

Page views 5894
Article views/downloads 7114
Get Citation

Connect on Social Media

Connect on Social Media

Recommendations of the Polish Society of Gynecologists and Obstetricians regarding caesarean sections

Miroslaw Wielgos1, Dorota Bomba-Opoń1, Grzegorz H. Breborowicz2, Krzysztof Czajkowski3, Romuald Debski4, Bozena Leszczynska-Gorzelak5, Przemyslaw Oszukowski6, Stanislaw Radowicki7, Mariusz Zimmer8
Pubmed: 30508218
Ginekol Pol 2018;89(11):644-657.

Abstract

In recent years, the worldwide percentage of deliveries by caesarean section has increased. However, this has only improved obstetric outcomes in low-income countries [1, 2]. Unfortunately, in Poland and other high-income countries, the rate of caesarean section, which is greater than 20%, is no longer associated with decreases in the perinatal mortality of mothers and their offspring. Currently in Poland, 43.85% of births are by caesarean section [3]. The increased number of caesarean sections may be associated with the development of perinatal medicine, and of diagnostics in particular, which can have an impact on the frequency of detecting foetal abnormalities. The results of randomised multicentre study carried out across various populations in the last two decades have indicated there is a greater risk to a child during vaginal delivery in cases of breech presentation [4]. Also, among women with one prior caesarean, planned elective caesarean section compared with planned vaginal birth was associated with a lower risk of fetal and infant death or serious infant outcome [5]. As a consequently, some national associations of obstetricians and gynecologists recommended the classification of pregnant women with these abnormalities for elective caesarean section. Epidemiological data from various populations indicate, however, that the main indications for caesarean section are still labour arrest and intrapartum fetal hypoxia [6, 7].

Article available in PDF format

View PDF Download PDF file

References

  1. World Health Organization Human Reproduction Programme, 10 April 2015. WHO Statement on caesarean section rates. Reprod Health Matters. 2015; 23(45): 149–150.
  2. Xie RH, Gaudet L, Krewski D, et al. Higher cesarean delivery rates are associated with higher infant mortality rates in industrialized countries. Birth. 2015; 42(1): 62–69.
  3. https://prog.nfz.gov.pl/app-jgp/Start.aspx.
  4. Hannah ME, Hannah WJ, Hewson SA, et al. Planned caesarean section versus planned vaginal birth for breech presentation at term: a randomised multicentre trial. Term Breech Trial Collaborative Group. Lancet. 2000; 356(9239): 1375–1383.
  5. Crowther CA, Dodd JM, Hiller JE, et al. Birth After Caesarean Study Group. Planned vaginal birth or elective repeat caesarean: patient preference restricted cohort with nested randomised trial. PLoS Med. 2012; 9(3): e1001192.
  6. Spong CY, Berghella V, Wenstrom KD, et al. Preventing the first cesarean delivery: summary of a joint Eunice Kennedy Shriver National Institute of Child Health and Human Development, Society for Maternal-Fetal Medicine, and American College of Obstetricians and Gynecologists Workshop. Obstet Gynecol. 2012; 120(5): 1181–1193.
  7. Groen RS, Trelles M, Caluwaerts S, et al. A cross-sectional study of indications for cesarean deliveries in Médecins Sans Frontières facilities across 17 countries. Int J Gynaecol Obstet. 2015; 129(3): 231–235.
  8. Pallasmaa N, Ekblad U, Aitokallio-Tallberg A, et al. Cesarean delivery in Finland: maternal complications and obstetric risk factors. Acta Obstet Gynecol Scand. 2010; 89(7): 896–902.
  9. Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers' Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG. 2011; 118 Suppl 1: 1–203.
  10. Creanga AA, Bateman BT, Butwick AJ, et al. Morbidity associated with cesarean delivery in the United States: is placenta accreta an increasingly important contributor? Am J Obstet Gynecol. 2015; 213(3): 384.e1–384.11.
  11. Berthelot-Ricou A, Lacroze V, Courbiere B, et al. Respiratory distress syndrome after elective caesarean section in near term infants: a 5-year cohort study. J Matern Fetal Neonatal Med. 2013; 26(2): 176–182.
  12. Jakobsson HE, Abrahamsson TR, Jenmalm MC, et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by caesarean section. Gut. 2014; 63(4): 559–566.
  13. Sevelsted A, Stokholm J, Bønnelykke K, et al. Cesarean section and chronic immune disorders. Pediatrics. 2015; 135(1): e92–e98.
  14. Cardwell CR, Stene LC, Joner G, et al. Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia. 2008; 51(5): 726–735.
  15. Zhang J, Troendle J, Mikolajczyk R, et al. The natural history of the normal first stage of labor. Obstet Gynecol. 2010; 115(4): 705–710.
  16. Laughon SK, Branch DW, Beaver J, et al. Changes in labor patterns over 50 years. Am J Obstet Gynecol. 2012; 206(5): 419.e1–419.e9.
  17. Graseck A, Tuuli M, Roehl K, et al. Fetal descent in labor. Obstet Gynecol. 2014; 123(3): 521–526.
  18. Tuuli MG, Frey HA, Odibo AO, et al. Immediate compared with delayed pushing in the second stage of labor: a systematic review and meta-analysis. Obstet Gynecol. 2012; 120(3): 660–668.
  19. Anim-Somuah M, Smyth R, Howell C. Epidural versus non-epidural or no analgesia in labour. Cochrane Database Syst Rev. 2005(4): CD000331.
  20. Wassen MM, Zuijlen J, Roumen FJ, et al. Early versus late epidural analgesia and risk of instrumental delivery in nulliparous women: a systematic review. BJOG. 2011; 118(6): 655–661.
  21. Harper LM, Caughey AB, Odibo AO, et al. Normal progress of induced labor. Obstet Gynecol. 2012; 119(6): 1113–1118.
  22. Rouse DJ, Weiner SJ, Bloom SL, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units Network (MFMU). Failed labor induction: toward an objective diagnosis. Obstet Gynecol. 2011; 117(2 Pt 1): 267–272.
  23. Simon CE, Grobman WA. When has an induction failed? Obstet Gynecol. 2005; 105(4): 705–709.
  24. Bomba-Opoń D, Drews K, Huras H, et al. Polish Gynecological Society Recommendations for Labor Induction. Ginekol Pol. 2017; 88(4): 224–234.
  25. Stanowisko Ekspertów Polskiego Towarzystwa Ginekologicznego w zakresie zastosowania kardiotokografii w położnictwie. Ginekol Pol. 2014; 85: 713–716.
  26. Neilson JP, Neilson JP, Neilson JP, et al. Fetal electrocardiogram plus heart rate recording for fetal monitoring during labour. Cochrane Database Syst Rev. 2000(2): CD000116.
  27. Rietberg CC, Elferink-Stinkens PM, Brand R, et al. Term breech presentation in The Netherlands from 1995 to 1999: mortality and morbidity in relation to the mode of delivery of 33824 infants. BJOG. 2003; 110(6): 604–609.
  28. Golfier F, Vaudoyer F, Ecochard R, et al. Planned vaginal delivery versus elective caesarean section in singleton term breech presentation: a study of 1116 cases. Eur J Obstet Gynecol Reprod Biol. 2001; 98(2): 186–192.
  29. Hofmeyr GJ, Hannah M, Lawrie TA. Planned caesarean section for term breech delivery. Cochrane Database Syst Rev. 2015(7): CD000166.
  30. Barrett JFR, Hannah ME, Hutton EK, et al. Twin Birth Study Collaborative Group. A randomized trial of planned cesarean or vaginal delivery for twin pregnancy. N Engl J Med. 2013; 369(14): 1295–1305.
  31. Vogel JP, Holloway E, Cuesta C, et al. Outcomes of non-vertex second twins, following vertex vaginal delivery of first twin: a secondary analysis of the WHO Global Survey on maternal and perinatal health. BMC Pregnancy Childbirth. 2014; 14: 55.
  32. Thomas PE, Petersen SG, Gibbons K. The influence of mode of birth on neonatal survival and maternal outcomes at extreme prematurity: A retrospective cohort study. Aust N Z J Obstet Gynaecol. 2016; 56(1): 60–68.
  33. Lannon SMR, Guthrie KA, Reed SD, et al. Mode of delivery at periviable gestational ages: impact on subsequent reproductive outcomes. J Perinat Med. 2013; 41(6): 691–697.
  34. Hofmeyr GJ, Kulier R. External cephalic version for breech presentation at term. Cochrane Database Syst Rev. 2000(2): CD000083.
  35. Hoffmann E, Oldenburg A, Rode L, et al. Twin births: cesarean section or vaginal delivery? Acta Obstet Gynecol Scand. 2012; 91(4): 463–469.
  36. Barrett JFR. Twin delivery: method, timing and conduct. Best Pract Res Clin Obstet Gynaecol. 2014; 28(2): 327–338.
  37. Lees C, Marlow N, Arabin B, et al. TRUFFLE Group. Perinatal morbidity and mortality in early-onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE). Ultrasound Obstet Gynecol. 2013; 42(4): 400–408.
  38. Figueras F, Gratacós E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014; 36(2): 86–98.
  39. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics. Practice Bulletin No. 173: Fetal Macrosomia. Obstet Gynecol. 2016; 128(5): e195–e209.
  40. Burkhardt T, Schmidt M, Kurmanavicius J, et al. Evaluation of fetal anthropometric measures to predict the risk for shoulder dystocia. Ultrasound Obstet Gynecol. 2014; 43(1): 77–82.
  41. Conway DL, Langer O. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia versus increased cesarean deliveries. Am J Obstet Gynecol. 1998; 178(5): 922–925.
  42. Anteby EY, Yagel S. Route of delivery of fetuses with structural anomalies. Eur J Obstet Gynecol Reprod Biol. 2003; 106(1): 5–9.
  43. Segel SY, Marder SJ, Parry S, et al. Fetal abdominal wall defects and mode of delivery: a systematic review. Obstet Gynecol. 2001; 98(5 Pt 1): 867–873.
  44. Wataganara T, Ngerncham S, Kitsommart R, et al. Fetal neck myofibroma. J Med Assoc Thai. 2007; 90(2): 376–380.
  45. Alfirevic Z, Milan SJ, Livio S. Caesarean section versus vaginal delivery for preterm birth in singletons. Cochrane Database Syst Rev. 2012(6): CD000078.
  46. Lee HC, Gould JB. Survival rates and mode of delivery for vertex preterm neonates according to small- or appropriate-for-gestational-age status. Pediatrics. 2006; 118(6): e1836–e1844.
  47. Warke HS, Saraogi RM, Sanjanwalla SM. Should a preterm breech go for vaginal delivery or caesarean section. J Postgrad Med. 1999; 45(1): 1–4.
  48. Jauniaux E, Ayres-de-Campos D. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Introduction. Int J Gynaecol Obstet. 2018; 140(3): 261–264.
  49. Jauniaux E, Chantraine F, Silver RM, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018; 140(3): 265–273.
  50. Jauniaux E, Bhide A, Kennedy A, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Prenatal diagnosis and screening. Int J Gynaecol Obstet. 2018; 140(3): 274–280.
  51. Silver RM, Barbour KD. Placenta accreta spectrum: accreta, increta, and percreta. Obstet Gynecol Clin North Am. 2015; 42(2): 381–402.
  52. Allen L, Jauniaux E, Hobson S, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. Int J Gynaecol Obstet. 2018; 140(3): 281–290.
  53. Sentilhes L, Kayem G, Chandraharan E, et al. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. Int J Gynaecol Obstet. 2018; 140(3): 291–298.
  54. Bręborowicz GH, Markwitz W, Gaca M, et al. Conservative management of placenta previa complicated by abnormal placentation. J Matern Fetal Neonatal Med. 2013; 26(10): 1012–1015.
  55. Jeejeebhoy FM, Zelop CM, Lipman S, et al. American Heart Association Emergency Cardiovascular Care Committee, Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Cardiovascular Diseases in the Young, and Council on Clinical Cardiology. Cardiac Arrest in Pregnancy: A Scientific Statement From the American Heart Association. Circulation. 2015; 132(18): 1747–1773.
  56. James DK, Steer PJ, Weiner CP, et al. High Risk Pregnancy. Management Options. Saunders. 2011.
  57. Jędrzejczak J, Bomba-Opoń D, Jakiel G, et al. Managing epilepsy in women of childbearing age - Polish Society of Epileptology and Polish Gynecological Society Guidelines. Ginekol Pol. 2017; 88(5): 278–284.
  58. Konsensus okulistyczno-położniczy w sprawie wskazań do rozwiązania porodu drogą cięcia cesarskiego z powodu zmian w narządzie wzroku. https://www.ptgin.pl/index.php/lekarze/rekomendacje2/rekomendacje.
  59. Holka-Pokorska J, Jarema M, Stefanowicz A, et al. Elective cesarean section on psychiatric indications – the phenomenon analysis, report of two cases and psychiatric clinical recommendations. Psychiatria Polska. 2016; 50(2): 357–373.
  60. Wielgoś M, Krzakowski M, Czajkowski K, et al. Standardy postępowania w przypadkach choroby nowotworowej u kobiety w ciąży Część I. Wiadomości ogólne: epidemiologia, diagnostyka, leczenie, poradnictwo genetyczne . Ginekologia i Perinatologia Praktyczna . 2016; 1(4): 172–188.
  61. Wielgoś M, Krzakowski M, Czajkowski K, et al. Standardy postępowania w przypadkach choroby nowotworowej u kobiety w ciąży Część III. Rak piersi, rak tarczycy. Ginekologia i Perinatologia Praktyczna. 2017; 2(1): 28–39.
  62. Wielgoś M, Krzakowski M, Czajkowski K, et al. Standardy postępowania w przypadkach choroby nowotworowej u kobiety w ciąży Część II. Rak szyjki macicy, guzy jajnika. Ginekologia i Perinatologia Praktyczna. 2017; 2(1): 28–39.
  63. Wielgoś M, Krzakowski M, Czajkowski K, et al. Standardy postępowania w przypadkach choroby nowotworowej u kobiety w ciąży Część IV. Nowotwory układu pokarmowego, rzadkie nowotwory . Ginekologia i Perinatologia Praktyczna . 2017; 2(2): 72–84.
  64. Management of Genital Herpes in Pregnancy. RCOG BASHH. 2014.
  65. British HIV Association guideline for the management of HIV infection in pregnant women 2012. HIV Medicine. 2014; 15: 1–77.
  66. Grobman WA, Lai Y, Landon MB, et al. Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Can a prediction model for vaginal birth after cesarean also predict the probability of morbidity related to a trial of labor? Am J Obstet Gynecol. 2009; 200(1): 56.e1–56.e6.
  67. Horenstein JM, Phelan JP. Previous cesarean section: the risks and benefits of oxytocin usage in a trial of labor. Am J Obstet Gynecol. 1985; 151(5): 564–569.
  68. Flamm BL, Goings JR, Fuelberth NJ, et al. Oxytocin during labor after previous cesarean section: results of a multicenter study. Obstet Gynecol. 1987; 70(5): 709–712.
  69. Bujold E, Blackwell SC, Gauthier RJ. Cervical ripening with transcervical foley catheter and the risk of uterine rupture. Obstet Gynecol. 2004; 103(1): 18–23.
  70. Lydon-Rochelle M, Holt VL, Easterling TR, et al. Risk of uterine rupture during labor among women with a prior cesarean delivery. N Engl J Med. 2001; 345(1): 3–8.